McKesson Is Down 25% in 45 Days. What History Says Now.

McKesson Corporation (MCK) has dropped 25.3% from its all-time high in just 45 days. This rapid decline has pushed the stock out of the yellow zone and into the red zone as of May 6, 2026.

Understanding the Red Zone Shift

Our data shows that McKesson Corporation (MCK) currently carries a Drawdown Severity Score™ of 5.6. This "Strong" rating indicates that the current sell-off is significantly more intense than the stock’s typical price fluctuations. For a company that usually experiences an average max drawdown of only -4.0%, a 25.3% decline represents a massive departure from normal trading behavior.

The transition from the yellow zone to the red zone is a critical marker in our proprietary data. While the yellow zone often represents standard market volatility or a healthy correction, the red zone suggests a deeper fundamental or technical shift. With the current price sitting at $743.67, well below the all-time high of $995.69, the stock is testing levels that are historically rare for this healthcare giant.

The speed of this move is particularly noteworthy. Most McKesson Corporation (MCK) pullbacks are relatively shallow and resolve quickly, with an average drawdown duration of 55 days. We are currently at day 45 of this cycle, meaning the stock has reached a "Strong" Drawdown Severity Score™ much faster than it typically reaches even its minor troughs.

Historical Context of 25% Declines

To understand where McKesson Corporation (MCK) might go next, we must look at how it has handled similar pressure in the past. Our data tracks 198 total historical drawdown events for this asset. Out of those nearly 200 instances, the stock has dropped 25% or more only 3 times.

This is an exceptionally small sample size, which suggests that a drawdown of this magnitude is a "black swan" type event for the company. When the Drawdown Severity Score™ reaches these levels, investors are looking at a scenario that has occurred in less than 2% of the stock's recorded history.

However, the historical data also provides a sobering look at recovery timelines for these rare, deep corrections. The average duration of comparable drops for McKesson Corporation (MCK) is 2,416 days. It is important to note the small sample size of 3 events when considering this average, as a single prolonged recovery period can heavily skew the data. Nevertheless, it illustrates that once the stock breaks past its typical -4.0% drawdown threshold and enters this level of severity, the path back to all-time highs has historically been measured in years rather than weeks.

Analyzing the Current Severity Score

The Drawdown Severity Score™ of 5.6 is calculated by comparing the current -25.3% drop against the stock’s entire volatility profile. Because McKesson Corporation (MCK) is generally a stable performer in the healthcare sector, our model views a 25% drop as a high-severity event.

In previous yellow zone periods, the stock often found support or stabilized before reaching the 45-day mark. The move into the red zone signifies that the current selling pressure has bypassed those historical support levels. We use the Drawdown Severity Score™ to filter out the "noise" of daily price movements and focus on the structural integrity of the stock's price trend.

When we look at the 198 historical drawdown events, the vast majority were minor blips that lasted less than two months. The current event is already approaching that 55-day average duration, but with a magnitude that is more than six times deeper than the average -4.0% drawdown. This divergence between duration and depth is what has pushed the severity score into the red.

Sector and Market Comparisons

While McKesson Corporation (MCK) is struggling, it is vital to view this drawdown in the context of its peers in the pharmaceutical distribution and healthcare services space. Typically, these stocks are viewed as defensive plays. A 25.3% decline in a defensive stock often signals broader concerns about reimbursement rates, regulatory shifts, or significant changes in drug distribution volumes.

Our data shows that when a blue-chip healthcare stock enters the red zone, it often correlates with a shift in institutional sentiment. The fact that this has only happened 3 times previously suggests that the market is currently pricing in a significant change to the company's long-term earnings power or risk profile.

Investors often monitor the Drawdown Severity Score™ to see if the score begins to plateau or if it continues to climb toward the higher end of the red zone. A score that remains stagnant while the price continues to fall slightly can sometimes indicate that the worst of the momentum is beginning to dissipate, though it does not guarantee an immediate recovery.

Monitoring the Path Forward

As of May 6, 2026, McKesson Corporation (MCK) remains firmly in the red zone. For the stock to move back into the yellow or green zones, we would need to see a sustained recovery toward the all-time high of $995.69.

The primary metric to watch is whether the drawdown exceeds the 25.3% mark or if the 45-day duration starts to stretch toward the multi-year recovery periods seen in previous major crashes. Because the Drawdown Severity Score™ is dynamic, it will react to every new closing price, providing a real-time assessment of whether the risk is accelerating or stabilizing.

We will continue to monitor the proprietary data for McKesson Corporation (MCK) to see if this becomes the fourth instance in history where the stock faces a multi-year climb back to parity, or if the current red zone entry is a shorter-term anomaly.